QUILT-2.015: A Study of AMG 479 With Exemestane or Fulvestrant in Postmenopausal Women With Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Tumors|Metastatic Cancer
Interventions: DRUG: AMG 479 or placebo administered with either exemestane or fulvestrant|DRUG: AMG 479 or placebo administered with either exemestane or fulvestrant|DRUG: AMG 479 or placebo administered with either exemestane or fulvestrant
Sponsor: NantCell, Inc.